Marina Blanco-Ruiz

Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study

P. Martínez-Sánchez, Cristina del Toro Pérez, María Victoria Mejías Olmedo, 2021, Atherosclerosis plus.

A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID‐19 years

L. Querol, J. Turon-Sans, L. Amaya Pascasio, 2024, medRxiv.